Overview

Detailed Summary

SastaSundar Ventures Limited (proposed Health X Platform Limited) operates an integrated digital healthcare platform combining pharmaceutical distribution (Retailer Shakti), a B2C pharmacy and wellness app (SastaSundar), diagnostics enablement, and franchise-led last-mile delivery via HealthBuddy. The company holds controlling interest in SastaSundar HealthBuddy Limited and aggregates digital enablement, automated fulfilment centres and retailer SaaS to serve consumers and 62,000+ pharmacies nationwide.
In Q3 FY26 SastaSundar reported consolidated healthcare operations revenue of ₹341.3 crore (total revenue ₹359.4 crore), up 22% year-on-year, with gross profit rising 55% and a gross margin of 7.6%; EBITDA loss narrowed to ₹14.8 crore and nine‑month PAT turned positive at ₹11.5 crore, driven materially by higher other income and operating efficiency improvements in procurement and fulfilment automation.
The company is aggressively investing in AI and platform monetization—announcing AI integration across counselling, operations and personalized recommendations, a Retail Air SaaS for retailers, and an AI studio budget—while launching the JITO private generic brand to capture value-accretive margin expansion; these initiatives are designed to shift revenue mix, increase gross margins and monetize proprietary data and digital properties.
Sastasundar emphasizes capital efficiency: management reports total capital raised of ₹352 crore and discloses a combined treasury of roughly ₹500 crore across group entities (about ₹403 crore in SastaSundar HealthBuddy Limited), consolidated borrowings near zero, and a compact working-capital profile; this liquidity is positioned to fund ₹100+ crore planned platform investments while preserving optionality for buybacks or corporate restructuring.

Sector: Healthcare Services
Industry: Healthcare Service Provider
Market Cap: 942 Cr
Volatility: Low Risk
P/E Ratio: 36.2
Industry P/E: 58.7
PEG Ratio: 0.8
P/B Ratio: 1.4
52W High: 375.00
52W Low: 230.00

Sales CAGR

1Y: -19.09%
3Y: —
5Y: 110.82%
10Y: -16.48%

Profit CAGR

1Y: -2382.74%
3Y: —
5Y: —
10Y: —

ROE

TTM: -0.30%
3Y: -5.41%
5Y: 11.05%
10Y: 5.88%

ROCE

TTM: -4.66%
3Y: -11.67%
5Y: 16.56%
10Y: 10.27%

Technicals

‌

Forecasts

Peers

Healthcare Healthcare Healthcare Services Healthcare Service Provider

Symbol	Watchlist	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
SURAKSHA		282.20	1,494 Cr	44.88	6.49	0.00	13.86	14.74	8.53
3BBLACKBIO		1194.00	1,117 Cr	19.45	3.75	0.31	16.47	21.74	17.06
HEALTHX		269.00	925 Cr	35.55	1.36	0.00	-0.30	-4.66	2.89
ONEGLOBAL		538.40	885 Cr	14.22	8.74	0.00	43.51	58.07	27.58
GAUDIUMIVF		78.20	868 Cr	38.24	5.83	0.00	55.85	55.95	21.30
CHANDAN		248.20	613 Cr	22.58	4.43	0.00	18.69	20.84	10.52
MADHAVBAUG		248.25	272 Cr	33.14	4.35	0.00	13.28	18.53	9.99
Median: 7 Co.	—	269.00	885 Cr	33.14	4.43	0.00	16.47	20.84	10.52

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Revenue	358	375	307	270	274	281	286	298	301	346
Expenses	355	371	317	273	278	305	311	292	324	356
Interest	0.24	0.24	0.27	0.10	0.06	0.05	0.01	0.09	0.04	0.17
Financing Profit	3.13	3.18	-11	-2.50	-4.80	-24	-25	5.98	-23	-11
Financing Margin %	0.87	0.85	-3.56	-0.92	-1.75	-8.44	-8.82	2.00	-7.52	-3.04
Other Income	9.71	20	18	29	-167	-14	22	25	5.34	14
Depreciation	2.20	2.31	2.53	1.61	1.45	1.43	1.34	1.17	1.33	2.17
Profit Before Tax	11	21	5.01	25	-174	-39	-4.63	30	-19	0.92
Tax %	-23.12	3.86	-583.23	-102.80	13.17	-1.99	479.70	11.89	17.17	59.78
Net Profit	13	20	34	50	-151	-40	18	27	-15	0.37
EPS in Rs	-2.55	-0.23	5.17	9.79	-34.40	-8.47	4.30	7.52	-3.99	0.35
Gross NPA %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net NPA %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Revenue	133	159	220	385	548	631	1,040	1,376	1,111	1,139
Expenses	155	175	256	441	562	680	1,084	1,370	1,167	1,187
Interest	2.81	0.52	1.96	0.70	1.05	1.64	0.87	1.01	0.22	0.21
Financing Profit	-25	-16	-38	-56	-15	-50	-45	4.41	-56	-48
Financing Margin %	-18.81	-10.01	-17.39	-14.55	-2.80	-7.96	-4.31	0.32	-5.06	-4.19
Other Income	3.96	2.62	2.43	3.12	3.43	6.45	-61	-26	49	-134
Depreciation	6.92	5.54	5.97	4.90	4.47	4.16	8.20	9.14	5.83	5.39
Profit Before Tax	-28	-19	-42	-58	-16	-48	-114	-30	-13	-187
Tax %	-2.21	-12.54	-2.66	9.40	-4.43	-509.09	19.93	119.19	537.91	21.72
Net Profit	-29	-15	-43	-52	-17	865	-99	5.85	-134	-147
EPS in Rs	-9.03	-5.18	-11.80	-12.19	-3.27	223.67	-22.70	2.80	-28.78	8.18
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	32	32	32	32	32	32	32	32	32	32
Reserves	186	163	144	111	178	168	795	722	731	638
Borrowings	18	20	12	0.00	5.01	9.79	0.00	0.00	0.00	0.00
Other Liabilities	20	36	48	88	100	83	451	452	387	305
Total Liabilities	256	251	236	230	316	293	1,278	1,206	1,150	974
Fixed Assets	126	125	117	116	114	110	93	104	108	100
CWIP	0.13	0.00	1.16	0.76	0.01	0.08	0.42	0.99	0.35	10
Investments	0.00	0.00	0.00	36	56	43	666	513	676	575
Other Assets	130	126	117	77	146	139	518	588	365	289
Total Assets	256	251	236	230	316	293	1,278	1,206	1,150	974

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	-12	-1.88	-49	-30	-69	-31	-207	-112	38	-17
Cash from Investing Activity	-1.06	3.80	15	-2.15	-22	21	220	133	-34	-1.13
Cash from Financing Activity	13	5.19	33	26	103	3.73	-11	-1.83	-2.35	-0.44
Net Cash Flow	-0.06	7.11	-1.52	-5.86	11	-5.41	0.96	19	1.89	-19

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoters	73.92%	73.92%	73.92%	73.92%	73.92%	73.92%	73.94%	74.11%	74.24%	74.24%	74.69%	74.84%
FIIs	0.31%	0.32%	0.49%	0.56%	0.61%	0.99%	1.71%	1.60%	1.88%	2.04%	2.25%	2.17%
DIIs	0.17%	0.17%	0.86%	0.96%	1.35%	1.98%	1.85%	2.06%	2.09%	2.07%	2.07%	2.60%
Public	25.59%	25.59%	24.72%	24.56%	24.12%	23.11%	22.50%	22.22%	21.79%	21.65%	20.99%	20.39%
Total Shareholders	14,752	14,633	14,053	14,544	14,493	15,360	14,093	13,693	13,452	13,012	12,287	11,845

Market Transactions

Unlock more with professional

Real-time bulk & block deal transactions
Export transaction data for analysis

Projection

Documents

Presentations

Concalls

Reports

Presentations

Investor Presentation

Q3 FY26

Investor Presentation

Q2 FY26

Investor Presentation

Q1 FY26

Available on Pro Plan